283 related articles for article (PubMed ID: 19679278)
1. Determinants of occurrence of aortic sclerosis in an aging population.
Ngo DT; Sverdlov AL; Willoughby SR; Nightingale AK; Chirkov YY; McNeil JJ; Horowitz JD
JACC Cardiovasc Imaging; 2009 Aug; 2(8):919-27. PubMed ID: 19679278
[TBL] [Abstract][Full Text] [Related]
2. Is it time for a new paradigm in calcific aortic valve disease?
Owens DS; Otto CM
JACC Cardiovasc Imaging; 2009 Aug; 2(8):928-30. PubMed ID: 19679279
[No Abstract] [Full Text] [Related]
3. Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeutics.
Sverdlov AL; Ngo DT; Chan WP; Chirkov YY; Gersh BJ; McNeil JJ; Horowitz JD
Eur Heart J; 2012 Oct; 33(19):2419-25. PubMed ID: 22771677
[TBL] [Abstract][Full Text] [Related]
4. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.
Novaro GM; Katz R; Aviles RJ; Gottdiener JS; Cushman M; Psaty BM; Otto CM; Griffin BP
J Am Coll Cardiol; 2007 Nov; 50(20):1992-8. PubMed ID: 17996566
[TBL] [Abstract][Full Text] [Related]
5. Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis.
Chirkov YY; Mishra K; Chandy S; Holmes AS; Kanna R; Horowitz JD
J Heart Valve Dis; 2006 Jan; 15(1):28-33. PubMed ID: 16480009
[TBL] [Abstract][Full Text] [Related]
6. Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valve.
Ali OA; Chapman M; Nguyen TH; Chirkov YY; Heresztyn T; Mundisugih J; Horowitz JD
Heart; 2014 May; 100(10):800-5. PubMed ID: 24743038
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between aortic sclerosis and left ventricular hypertrophy in elderly subjects.
Nightingale AK; Sverdlov AL; Rajendran S; Mishra K; Heresztyn T; Ngo DT; Horowitz JD
Int J Cardiol; 2011 Jul; 150(1):33-8. PubMed ID: 20236713
[TBL] [Abstract][Full Text] [Related]
8. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.
Rajendran S; Willoughby SR; Chan WP; Liberts EA; Heresztyn T; Saha M; Marber MS; Norman RJ; Horowitz JD
Atherosclerosis; 2009 Jun; 204(2):509-14. PubMed ID: 19027116
[TBL] [Abstract][Full Text] [Related]
10. Correlation of high sensitivity C-reactive protein and calcific aortic valve disease.
Jeevanantham V; Singh N; Izuora K; D'Souza JP; Hsi DH
Mayo Clin Proc; 2007 Feb; 82(2):171-4. PubMed ID: 17290723
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area.
Ferreira-González I; Pinar-Sopena J; Ribera A; Marsal JR; Cascant P; González-Alujas T; Evangelista A; Brotons C; Moral I; Permanyer-Miralda G; García-Dorado D; Tornos P
Eur J Prev Cardiol; 2013 Dec; 20(6):1022-30. PubMed ID: 22679252
[TBL] [Abstract][Full Text] [Related]
12. Carotid intima-media thickness, carotid distensibility and mitral, aortic valve calcification: a useful diagnostic parameter of systemic atherosclerotic disease.
Sgorbini L; Scuteri A; Leggio M; Gianni W; Nevola E; Leggio F
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):342-7. PubMed ID: 17443100
[TBL] [Abstract][Full Text] [Related]
13. Association between pentraxin 3 levels and aortic valve calcification.
Norimatsu K; Miura S; Suematsu Y; Shiga Y; Miyase Y; Nakamura A; Zhang B; Saku K
J Cardiol; 2016 Jul; 68(1):76-82. PubMed ID: 26388550
[TBL] [Abstract][Full Text] [Related]
14. In patients with aortic stenosis increased flow-mediated dilation is independently associated with higher peak jet velocity and lower asymmetric dimethylarginine levels.
Schumm J; Luetzkendorf S; Rademacher W; Franz M; Schmidt-Winter C; Kiehntopf M; Figulla HR; Brehm BR
Am Heart J; 2011 May; 161(5):893-9. PubMed ID: 21570519
[TBL] [Abstract][Full Text] [Related]
15. Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients.
Willoughby SR; Rajendran S; Chan WP; Procter N; Leslie S; Liberts EA; Heresztyn T; Chirkov YY; Horowitz JD
J Am Coll Cardiol; 2012 Sep; 60(10):887-94. PubMed ID: 22682555
[TBL] [Abstract][Full Text] [Related]
16. Aortic valve sclerosis is associated with systemic endothelial dysfunction.
Poggianti E; Venneri L; Chubuchny V; Jambrik Z; Baroncini LA; Picano E
J Am Coll Cardiol; 2003 Jan; 41(1):136-41. PubMed ID: 12570956
[TBL] [Abstract][Full Text] [Related]
17. Arterial wave reflections and determinants of endothelial function a hypothesis based on peripheral mode of action.
Weber T; Maas R; Auer J; Lamm G; Lassnig E; Rammer M; O'Rourke MF; Böger RH; Eber B
Am J Hypertens; 2007 Mar; 20(3):256-62. PubMed ID: 17324736
[TBL] [Abstract][Full Text] [Related]
18. Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA).
Ngo DT; Heresztyn T; Mishra K; Marwick TH; Horowitz JD
Nitric Oxide; 2007 Mar; 16(2):197-201. PubMed ID: 17126043
[TBL] [Abstract][Full Text] [Related]
19. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly.
Otto CM; Lind BK; Kitzman DW; Gersh BJ; Siscovick DS
N Engl J Med; 1999 Jul; 341(3):142-7. PubMed ID: 10403851
[TBL] [Abstract][Full Text] [Related]
20. Aortic valve sclerosis is a sign of increased arterial stiffness in clinically asymptomatic subjects.
Korkmaz L; Ağaç MT; Bektas H; Varol MO; Erkan H; Acar Z; Kurt D; Çelik Ş
Cardiol J; 2013; 20(3):318-22. PubMed ID: 23788307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
